CS Paper Radar

CaMeWM: A Causal Medical World Model for Generative Tumor Evolution and Treatment Planning

Huanlong Gao, Xuelei He, Fengjun Zhao, Xiaowei He

cs.CV cs.LG ·submitted 2026-10-17 11:53 UTC · v1

Abstract

Treatment planning is intrinsically counterfactual: clinicians must compare how a patient's tumor and survival would evolve under competing regimens, whereas a retrospective cohort records only the regimen received and one follow-up scan. A treatment-conditioned generator trained on such data can therefore reproduce historical treatment allocation rather than simulate the interventional disease dynamics needed to rank regimens. We introduce \textbf{CaMeWM}, a causal medical world model for supported post-TACE tumor evolution and treatment planning. CaMeWM implements one intervention-to-decision loop rather than three independent prediction tasks: it first admits a queried regimen only for clinically comparable histories with empirical treatment support; it then generates a distribution of lesion-local follow-up worlds through an action-conditioned response descriptor, deterministic anchor, and residual 3D diffusion transition; and it finally maps sampled worlds to restricted mean survival time (RMST) with a response-Cox utility model. Under pre-treatment adjustment and positivity, this loop estimates a prespecified, support-restricted g-formula target; all selection and nuisance estimation are fold-local, and the induced policy is evaluated by cross-fitted, censoring-adjusted doubly robust estimation. Across 79 paired out-of-fold episodes, CaMeWM achieves 0.618 SSIM and 0.528 change-map SSIM for follow-up CT transition, while its generated-world survival pathway attains a 0.615 C-index; factual-only AIPW estimates a 9.60-week RMST gain (95\% CI 0.61--18.13) for the frozen policy. CaMeWM provides an inspectable basis for retrospective, support-restricted treatment planning.

Comment
30 pages,8 figures,12 tables,including supplementary material

Closest papers

Nearest neighbours by meaning across the whole index.

CoRe-WM: Conditioned Response-State World Modeling for Longitudinal Treatment-Response Prediction in Breast DCE-MRI

cs.CV ·2026-10-18 ·Lin Zhao, Bowen Chen, Qiaohui Gao, Shaowen Wan, Xiang Li +2 more
similarity 0.69
Abstract

Pathologic complete response (pCR) after neoadjuvant chemotherapy is a key prognostic indicator in aggressive breast cancer, yet existing prediction approaches either rely on pretreatment imaging alone, missing the patient's evolving response, or optimize multi-visit classifiers under direct outcome supervision, coupling representation learning with the clinical endpoint. We formulate longitudinal pCR prediction as a world-modeling problem and propose Conditioned Response-state World Modeling (CoRe-WM), which learns a latent state-transition model that predicts the next imaging state from the observed sequence. The transition function is conditioned on patient clinical profile and assigned therapy through additive shift and feature-wise modulation, enabling patient- and treatment-specific dynamics. A Factorized Response State pathway further decouples treatment-response dynamics from imaging appearance by encoding the structural prior that response manifests primarily in lesion morphology. After pretraining, all parameters are frozen and a linear readout predicts pCR at each clinical decision point. We evaluate CoRe-WM on I-SPY2 under five-fold cross-validation and assess cross-cohort transfer on I-SPY1. CoRe-WM achieves the highest discrimination among all evaluated methods at every prospective decision point, and demonstrates robust cross-cohort transfer. Ablation studies identify patient-profile conditioning and the factorized response pathway as the principal contributors. These results establish world-model-based representation learning as a promising framework for outcome prediction in oncology and beyond.

0.20

Causal multi-modal AI for personalized chemosensitivity prediction

cs.AI ·2026-09-11 ·Dhruva Biswas, Jeroen Berrevoets, Alec McClean, Linus Bao, Jungkyu Park +29 more
highly cited similarity 0.68
Abstract

Chemotherapy improves survival for some patients with breast cancer, but doctors cannot reliably predict who. Current guidelines rely on recurrence scores as a proxy for treatment benefit, which may contribute to the overprescription of chemotherapy. Here we present a causal multi-modal AI model that predicts personalized chemosensitivity using routinely collected pathology and clinical information. We developed our model on a multi-national dataset of 9,141 patients (twelve cohorts, nine countries) and evaluated it on another 1,994 patients (five cohorts, three countries). The model generated treatment-specific recurrence probabilities for each patient, with near-perfect calibration and strong prognostic discrimination across both 5- and 10-year follow-up horizons. Moreover, its chemotherapy benefit predictions demonstrated robust predictive performance, and out-performed existing recurrence-score-based tests. Compared to the standard of care, using the model to support personally tailored therapeutic decisions could reduce the number of patients receiving chemotherapy by 30% while achieving the same recurrence-free rate. Tumors predicted to be highly chemosensitive displayed concordant molecular and morphological programs of proliferation, cell cycle progression, and replication stress. The model's predictive capabilities transferred zero-shot to non-breast cancers, indicating our causal multi-modal AI approach may provide a universal strategy to predict treatment outcomes across cancer types.

0.52

PerturbRx: Learning Treatment-Conditioned Latent Transitions for Patient Drug Response Prediction

cs.LG q-bio.QM ·2026-08-21 ·Yoshitaka Inoue, Minoh Jeong, Alfred Hero, Rui Kuang, Augustin Luna
similarity 0.67
Abstract

Scarce data and tumor heterogeneity limit patient-level cancer treatment-response prediction. Existing approaches predict response from pretreatment molecular profiles and drug representations, without explicitly modeling the molecular changes expected under treatment. We propose PerturbRx, a treatment-conditioned representation learning framework that learns intervention-induced latent transitions and uses them as patient-drug response features. PerturbRx trains a drug- and dose-conditioned transition predictor from context-matched but cell-unpaired control and treated single-cell populations, then freezes and transfers the predictor to pretreatment patient profiles without requiring post-treatment measurements. The transition is combined with patient and drug representations to predict response. Across TCGA and patient-derived xenograft benchmarks, PerturbRx achieves the strongest aggregate predictive performance among the evaluated methods. These results support perturbation-pretrained latent transitions as useful representations for patient-level drug-response prediction.

0.25

Adaptive Chemotherapy Control under Tumor Heterogeneity via Reinforcement Learning

cs.LG eess.SY ·2026-09-10 ·Bereket Sitotaw Kidane, Md Samiul Haque Motayed, Shuo Wang
publishedbenchmark similarity 0.67
Abstract · 6 pages. Published in the 2026 American Control Conference (ACC)

Designing effective chemotherapy regimens is hindered by tumor heterogeneity and drug resistance, which complicate the deployment of patient-specific model-based optimal control across diverse populations. We develop and compare closed-loop deep reinforcement learning (DRL) dosing policies with continuous (TD3) and discrete (DQN) action spaces trained on a high-dimensional heterogeneous tumor model. The DRL policies are benchmarked against a Pontryagin's Maximum Principle (PMP)-derived open-loop benchmark. We assess generalization under parametric heterogeneity using a 100-patient virtual cohort with plus or minus 10 percent uniform perturbations in growth and drug-sensitivity parameters. Across this cohort, TD3 achieves higher average tumor reduction, while DQN yields tighter inter-patient dosing consistency, revealing a clear efficacy-consistency trade-off in this study. Our simulations assume full observation of all tumor subpopulations; translation to sparse and noisy clinical measurements will require partial-observability formulations and/or state estimation. Overall, the results show that simulation-trained DRL can learn state-dependent feedback dosing policies that complement open-loop optimal control benchmarks.

0.33

HiSTOR: Structured Treatment-outcome Representation Learning for High-Dimensional Longitudinal Data

cs.LG cs.AI ·2026-10-13 ·Chuanqi Lao, Junzhou Huang, Qiao Liu
similarity 0.65
Abstract

Estimating potential outcomes under alternative treatment sequences is essential for personalized decision-making, but remains challenging with high-dimensional covariates and time-varying confounding. In this study, we propose HiSTOR (High-dimensional Structured Treatment-Outcome Representation), an end-to-end framework that integrates nonlinear dimension reduction with longitudinal counterfactual prediction. The central idea is to learn structured low-dimensional representations of both current patient states and evolving histories, according to their shared and distinct relationships with treatment assignment and outcomes. This extends latent-space covariate adjustment to longitudinal settings, jointly addressing covariate dimensionality and historical complexity. The resulting framework supports one-step and multi-step outcome prediction under specified treatment sequences. Experiments on CVSim and CancerSim demonstrate the superiority of HiSTOR across varying covariate dimensions, confounding strengths, and prediction horizons compared to state-of-the-art methods. To sum up, HiSTOR offers a unified approach to connecting high-dimensional covariate adjustment with longitudinal potential-outcome prediction.

0.18

Admissible Diffusion for Multimodal Interventional Trajectories

cs.LG ·2026-09-28 ·Xing Han, Shravan Chaudhari, Jiarui Shao, Paul Pu Liang, Suchi Saria
similarity 0.65
Abstract · 15 pages, 3 figures, 7 tables

Generating a plausible clinical trajectory does not establish what would happen under a different treatment. We present ADMIT, a framework combining irregular multimodal representations, treatment-conditioned latent diffusion and explicit constraints on generated states or actions. We formulate its interventional target through sequential g-computation and distinguish causal assumptions from constraint satisfaction. Its admissibility mechanism translates physiological prior knowledge into explicit constraints on generated states and proposed actions. Treatment-exposure dynamics condition latent transitions, while state projection or action gating applies the constraints during rollout so that they influence subsequent trajectory generation. In our preliminary experiments, multimodal inputs improved supervised hidden-state recovery and reduced treatment-contrast error. In a simulated dosing-schedule experiment with leak-free history encoding, ADMIT predicted most of the tumor-volume change caused by redistributing a fixed total dose. An exposure input improved these predictions around a temporary dose reduction whether or not the assumed clearance rate was correct, but reduced the predicted size of a dose effect, and a deterministic recurrent baseline matched ADMIT's average predictions. Exposure projection reduced constraint violations, although enforcement remained incomplete. Semi-synthetic experiments using eICU context illustrated treatment-response generation under fixed and adaptive policies. Observational examples further characterize model treatment sensitivity. ADMIT provides a framework for testing whether complementary observations and physiological restrictions improve intervention trajectories, with representation recovery, effect accuracy and rule enforcement assessed separately.

0.26

Intervention-Aware Clinical World Model for Post-Op Outcome Forecasting in Cardiology

cs.LG cs.CV ·2026-08-13 ·Yunsung Chung, Yingshuo Liu, Abboud F. Hassan, Han Feng, Mary M. Maleckar +2 more
published similarity 0.65
Abstract · Medical World Models (MWM) Workshop at MICCAI 2026

Many clinical prediction models treat post-intervention outcomes as a one-step mapping from baseline measurements to a future endpoint. However, recovery after a procedure often unfolds as an irregular trajectory: clinical observations, medication changes, repeat interventions, and physiological measurements are recorded asynchronously and can change risk assessment over time. We propose an intervention-aware clinical world model that represents each patient with a structured latent state and evolves it through time-ordered post-intervention events. The model first encodes baseline imaging into a 3D spatial latent state. It then updates this state using procedural context, static covariates, elapsed time, and peri-event physiological embeddings. Follow-up imaging provides training-only supervision through a latent forecasting objective. We apply the framework to atrial fibrillation ablation. During the 90-day recovery window, irregular post-procedure records provide clinically meaningful evidence for long-term recurrence risk. In repeated internal cross-validation on DECAAF-II, our model achieves AUROC 0.756 and AUPRC 0.777 for recurrence prediction. It also achieves a scar-extent MAE of 2.971 percentage points without requiring follow-up MRI intensities at inference. The learned state supports recurrence-risk queries at different horizons and retrospective input editing of blanking-period records.

0.46

CACSurv: Concordance-Aligned Comparative Learning with Large Language Models for Cancer Survival Prediction

cs.AI ·2026-08-17 ·Tianqi Xiang, Qixiang Zhang, Xinpeng Ding, Yi Li, Xiaomeng Li
benchmarkcode/data similarity 0.64
Abstract

Cancer survival prediction supports treatment planning, risk stratification, and follow-up management. Existing methods use structured clinical variables, whole-slide images, genomic profiles, or multimodal inputs, while patient reports remain underexplored. We study report-centric survival prediction using reports that organize pathological, clinical, and molecular evidence. Large language models (LLMs) can reason over such reports, but case-wise time regression introduces two mismatches. First, a formulation mismatch arises because survival evaluation depends on ordering comparable patients, whereas independent time predictions do not enforce ranking consistency. Second, a supervision mismatch arises because a censored patient's observed time indicates survival beyond that point and cannot serve as an exact regression target, although it still implies orderings relative to patients who died earlier. To address these mismatches, we propose CACSurv, a Concordance-Aligned Comparative framework for report-centric survival prediction. CACSurv reformulates survival modeling as mini-cohort comparative reasoning, where an LLM predicts relative prognostic orderings. We introduce concordance-aligned rewards derived from comparable relations under right censoring, enabling censored outcomes to provide ranking supervision without exact event-time targets. At inference, Monte Carlo Reference Aggregation compares each patient with sampled references and aggregates positions into a cohort-level ranking. We establish TCGA-SurvReport, a benchmark covering six TCGA cancer cohorts. CACSurv achieves the highest C-index on all six cohorts and an average C-index of 0.722, outperforming the strongest published survival model by 6.5 percentage points and the strongest LLM time-regression baseline by 4.2 percentage points. Our code, models, and dataset will be available at https://github.com/xmed-lab/CACSurv.

0.52